Oriola Corp Class B · OMXHEX:ORIOLA
Oriola Corp Class B — Q1 2022 Earnings Presentation
24 slides from Oriola Corp Class B's earnings presentation, Apr 28, 2022
Slide 1: Oriola Corporation Interim Report January-March 2022
Oriola Corporation Interim Report January-March 2022
Slide 2: New reporting structure
New reporting structure Oriola Services segment – continuing operations Combines the old business areas Pharma and Retail in Finland and Sweden Consumer segment – discontinued operations Pharmacy operations in Sweden Note: Based on earlier announced new operating model and a framework merger agreeme
Slide 3: Q1 2022 key points
Q1 2022 key points Turnaround actions and market demand improved profit – market environment uncertain • Total Oriola net sales increased by 7% and comparable adjusted EBIT to EUR 11.5 (0.3) million • Continuing operations net sales increased by 8% and adjusted EBIT to EUR 4.7 (0.9) million • Discon
Slide 4: Continuing and discontinued operations: Comparable adjusted EBIT increased to EUR 11.5 million
Q1 2022 Continuing and discontinued operations: Comparable adjusted EBIT increased to EUR 11.5 million, adjusted EBIT at EUR 15.0 million Net sales1 Adjusted EBIT development2 EUR million EUR million 2020 2021 2022 +7% 500 18 15 400 3.5 12 300 0,0 499 9 460 450 482 468 439 466 466 200 436 7,4 15,0 6
Slide 5: Key figures Q1 2022 for continuing and discontinued operations
Key figures Q1 2022 for continuing and discontinued operations Invoicing Q1 Net sales Q1 Adjusted EBIT Q11 EUR million EUR million EUR million +7% 1 200 500 16 15.0 +6% 14 1 000 400 3.5 12 800 10 300 600 482 8 460 450 965 942 1 001 200 397 894 388 6 400 848 11,5 4 100 6,9 200 5,8 2 3,7 0 0 0 0.3 201
Slide 6: Key figures Q1 2022 for continuing operations
Key figures Q1 2022 for continuing operations Invoicing Q1 Net sales Q1 Adjusted EBIT Q11 EUR million EUR million EUR million 1 000 400 +8% 7 +6% 350 6 800 300 5 250 600 4 200 887 355 373 856 834 346 3 400 747 796 150 303 291 4,7 2 100 200 1 2,3 50 1,5 0,9 0,9 0 0 0 2018 2019 2020 2021 2022 2018 201
Slide 7: Key figures Q1 2022 for discontinued operations
Key figures Q1 2022 for discontinued operations Invoicing Q1 Net sales Q1 Adjusted EBIT Q11 EUR million EUR million EUR million 250 250 14 +3% +3% 12 200 200 10.3 10 8 3.5 150 150 6 100 206 204 210 100 202 200 205 194 192 189 188 4 6,8 5,4 2 3,6 50 50 2,8 0 -0.6 0 0 -2 2018 2019 2020 2021 2022 2018
Slide 8: Operating environment
& Oriola Operating _ c ® = c fe) = > c ®
Slide 9: Oriola Services markets were growing in Q1
Oriola Services markets were growing in Q1 Market share wholesale Market share dose dispensing Sweden Sweden Pharmaceutical market in value Q1: Total market 51 BSEK Oriola 45% (46%) Oriola 42% (43%) Sweden +7.6% ~ 250,000 Others 55% (54%) patients Others 58% (57%) Source: IQVIA and Oriola estimate S
Slide 10: Pharmacy market value and volume grew in Q1 in Sweden
Pharmacy market value and volume grew in Q1 in Sweden Pharmacy market value development in Sweden in Q1: +9.7% Pharmacy market volume grew in Sweden in Q1 Online pharmacy market size in Sweden Total online pharmacy market grew by 12% in BSEK Jan-Mar 2022 (41%) and its share of the total Market share
Slide 11: Segment reviews Q1 2022
& Oriola Segment reviews Q1 2022
Slide 12: Continuing operations Oriola Services Q1: Improved market demand and operational efficiency
Continuing operations Oriola Services Q1: Improved market demand and operational efficiency • Market demand growing in both countries Adjusted EBIT 1 EUR million 2020 2021 2022 • Invoicing increased by 6.3% to EUR 886.7 million, (on a constant currency basis invoicing increased by 8.9%) 10 8,7 • Net
Slide 13: Discontinued operations Consumer Q1: Increased online sales and efficient e-commerce operations
Discontinued operations Consumer Q1: Increased online sales and efficient e- commerce operations • Consumer activity and demand grew Y/Y Adjusted EBIT 1 • Net sales increased by 2.7% to EUR 205.1 million, EUR million 2020 2021 2022 (on a constant currency basis net sales increased by 12 6.4%), drive
Slide 14: Financials Q1 2022
& Oriola Financials Q1 2022
Slide 15: Q1: Profit for the period and EPS increased
Continuing and discontinued operations Q1: Profit for the period and EPS increased Profit for the period, continuing and Earnings per share, continuing and discontinued operations discontinued operations EUR million EUR 2020 2021 2022 2020 2021 2022 10 0.08 8,8 8 6,8 0.06 0,05 6 5.1 5.3 0.04 0.04 4,
Slide 16: Q1: Operating cash flow increased, driven by improved profitability and working capital
Continuing and discontinued operations Q1:Operating cash flow increased, driven by improved profitability and changes in working capital Quarterly net cash flow from operating activities1 Q1 YTD 2022 change in cash1 EUR million EUR million 2020 2021 2022 80 200 60 46 42 150 21,4 40 29 28 28,7 -2.4 2
Slide 17: Q1: Net Interest-Bearing Debt declined Y/Y
Q1: Net Interest-Bearing Debt declined Y/Y Net interest-bearing debt1 Net interest-bearing debt items EUR million EUR million 2020 2021 2022 160 Net interest-bearing debt item 31 Mar 2022 31 Mar 20211 140 Bank loans 64.1 116.3 (syndicated Bank & term) 120 Commercial papers 74.9 73.5 100 Advance paym
Slide 18: Equity ratio and gearing improved in Q1 2022
Equity ratio and gearing improved in Q1 2022 Equity ratio1 Gearing2 % % 2020 2021 2022 2020 2021 2022 25 125 19,9 20,1 99,8 102,3 19.1 20 18.0 100 91.8 94.7 14,8 75,0 15 14.1 14.0 75 13.3 64,1 12,4 53,8 10 50 46.5 5 25 8,3 0 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 2 2020 and 2021 figures include discontinued oper
Slide 19: Outlook for 2022
Outlook for 2022 The comparable adjusted EBIT is estimated to increase from the 2021 level. The COVID-19 pandemic continues and severity as well as duration of the pandemic remain unclear in Oriola’s operating environment. Furthermore, the recent overall inflationary increases and related cost press
Slide 20: Turnaround continues
Turnaround continues = |
Slide 21: Short-term action plan to improve profitability during 2022
Short-term action plan to improve profitability during 2022 – impacts fully visible in 2023 1. Cost savings • Increased transparency and customer focus via country-based structure: annual cost Simplified savings EUR 7 million - from the first quarter of 2022 onwards operating model • Divestment of p
Slide 22: Q1 2022 Key take-aways
Q1 2022 Key take-aways Turnaround actions and market demand improved profit – market environment uncertain New segment Both Oriola Planned Turnaround Russia's military structure Services and pharmacy actions continued offensive against – Consumer net operations merge – Ukraine further Continuing sal
Slide 23: Our next events
Our next events: 22/7/2022 Half year financial report 1-6/2022 27/10/2022 Interim Report 1-9/2022 Contact: investor.relations@oriola.com Thank you!
Slide 24: Health for life
& Oriola Health for life